BridgeBio (NasdaqGS:BBIO) Q4 2025 Earnings call February 24, 2026 04:30 PM ET Company ParticipantsAdi Jayaraman - Senior Managing DirectorAndrew Tsai - Managing DirectorChinmay Shukla - SVP of Strategic FinanceJustin To - CEO of Skeletal DysplasiasMatthew Outten - Chief Commercial OfficerNeil Kumar - CEOTom Trimarchi - President and CFOConference Call ParticipantsBiren Amin - Managing Director and Investment Analyst in Life SciencesEliana Merle - Senior Biotech Equity Research AnalystMani Foroohar - Senior ...

Day One Biopharmaceuticals (NasdaqGS:DAWN) Q4 2025 Earnings call February 24, 2026 04:30 PM ET Company ParticipantsBrittany Socha - Equity Research AssociateCharles N. York II - COO and CFOJeremy Bender - CEOJoey Perrone - Senior Vice President of Finance and Investor RelationsLauren Merendino - CCOMichael Vasconcelles - Head of Research and DevelopmentNick Lorusso - Equity Research Vice PresidentPoorna Kannan - Equity Research AssociateConference Call ParticipantsAndres Y. Maldonado - Senior Biotechnology ...

Alphatec (NasdaqGS:ATEC) Q4 2025 Earnings call February 24, 2026 04:30 PM ET Company ParticipantsBen Haynor - Managing Director of Medical Technology ResearchPat Miles - CEOTodd Koning - CFOConference Call ParticipantsMatthew Blackman - Research AnalystOperatorGood afternoon, everyone, and welcome to the webcast of ATEC's fourth quarter and full year 2025 financial results. We would like to remind everyone that participants on the call will make forward-looking statements. These statements are based on curr ...

Vaxcyte (NasdaqGS:PCVX) Q4 2025 Earnings call February 24, 2026 04:30 PM ET Company ParticipantsAndrew Guggenhime - President and CFOAsad Haider - Managing DirectorDina Ramadane - Biotech Equity Research AssociateEvan Wang - VP of Equity ResearchGrant Pickering - CEOJim Wassil - EVP and COOJonathan Miller - Managing Director of Biotech and Pharma Equity ResearchMike Miletich - Chief Commercial OfficerConference Call ParticipantsCarter Gould - Managing Director and Senior AnalystJoseph Stringer - Senior Anal ...

Vaxcyte (NasdaqGS:PCVX) Q4 2025 Earnings call February 24, 2026 04:30 PM ET Company ParticipantsAndrew Guggenhime - President and CFOAsad Haider - Managing DirectorDina Ramadane - Biotech Equity Research AssociateEvan Wang - VP, Equity ResearchGrant Pickering - CEOJim Wassil - EVP and COOJonathan Miller - Equity Research AssociateMike Miletich - Chief Commercial OfficerConference Call ParticipantsCarter Gould - Managing Director and Senior AnalystJoseph Stringer - Senior AnalystRoger Song - Senior Equity Re ...

Solid Power (NasdaqGS:SLDP) Q4 2025 Earnings call February 24, 2026 04:30 PM ET Speaker6Good day, welcome to the Solid Power fourth quarter 2025 earnings conference call. All participants will be in listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by 0. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star then 1 on a touch-tone phone. To withdraw the question, please press star th ...

Day One Biopharmaceuticals (NasdaqGS:DAWN) Q4 2025 Earnings call February 24, 2026 04:30 PM ET Speaker8Hello, ladies and gentlemen, and welcome to the Day One Biopharmaceuticals's fourth quarter and full year 2025 financial and operating results conference call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session. Please be advised that this conference call is being recorded. I would now like to turn the call over to Joey Perrone, Senior Vice Presid ...

Clean Energy Fuels (NasdaqGS:CLNE) Q4 2025 Earnings call February 24, 2026 04:30 PM ET Speaker6Hello, welcome everyone joining today's Clean Energy Fuels Fourth Quarter 2025 earnings conference call. At this time, all participants are in a listen-only mode. Later, you will have the opportunity to ask questions during the question and answer session. To register to ask a question at any time, please press star 1 on your telephone keypad. Please note this call is being recorded. We are standing by if you shou ...

Globus Medical (NYSE:GMED) Q4 2025 Earnings call February 24, 2026 04:30 PM ET Speaker10Welcome to Globus Medical's fourth quarter and full year 2025 earnings call. At this time, all lines will be on mute, and a question and answer session will be held after the prepared remarks. I will now turn the call over to Brian Kearns, Senior Vice President of Business Development and Investor Relations. Mr. Kearns, please go ahead.Speaker1Thank you, Dana. Thank you everyone for being with us today. Joining today's c ...

Tigo Energy (NasdaqCM:TYGO) Q4 2025 Earnings call February 24, 2026 04:30 PM ET Speaker4Good afternoon! Welcome to Tigo Energy's fiscal fourth quarter and full year 2025 earnings conference call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session. Joining us today from Tigo are Zvi Alon, CEO, and Bill Rossi, CFO. As a reminder, this call is being recorded. I will now turn the call over to Bill Rossi, Chief Financial Officer ...